Literature DB >> 12745019

Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies.

Kazunori Kawamura1, Philip H Elsinga, Tadayuki Kobayashi, Shin-ichi Ishii, Wei-Fang Wang, Kiyoshi Matsuno, Willem Vaalburg, Kiichi Ishiwata.   

Abstract

We prepared sigma(1)-receptor selective 1-([4-methoxy-(11)C]-3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine ([(11)C]SA4503) and its fluorinated analog 1-([4-methoxy-(11)C]3,4-dimethoxyphenethyl)-4-[3-(4-fluorophenyl)propyl]piperazine ([(11)C]SA5845), and their [(11)C]ethoxy and [(18)F]fluoroethoxy analogs, and evaluated their potential for positron emission tomography studies. [(11)C]SA4503 is most selective for sigma(1) receptors, and the other five showed affinities for sigma(1) and sigma(2) receptors with a different extent. All radioligands showed the receptor-specific binding in the brain, and visualized similar regional brain distributions by ex vivo autoradiography. The [(11)C]ethoxy analogs were relatively labile for metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745019     DOI: 10.1016/s0969-8051(02)00439-0

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  12 in total

1.  Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET.

Authors:  Nisha K Ramakrishnan; Anniek K D Visser; Marianne Schepers; Gert Luurtsema; Csaba J Nyakas; Philip H Elsinga; Kiichi Ishiwata; Rudi A J O Dierckx; Aren van Waarde
Journal:  Psychopharmacology (Berl)       Date:  2014-03-18       Impact factor: 4.530

2.  Altered sigma-1 receptor expression in two animal models of cognitive impairment.

Authors:  Nisha K Ramakrishnan; Krisztina Marosi; Csaba J Nyakas; Chantal Kwizera; Philip H Elsinga; Kiichi Ishiwata; Paul G M Luiten; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

3.  Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligands.

Authors:  Zhude Tu; Shihong Li; Aixiao Li; Michelle Taylor; David Ho; Maninder Malik; Robert R Luedtke; Robert H Mach
Journal:  Medchemcomm       Date:  2013-09       Impact factor: 3.597

4.  Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor Occupancy.

Authors:  Nisha K Ramakrishnan; Marianne Schepers; Gert Luurtsema; Csaba J Nyakas; Philip H Elsinga; Kiichi Ishiwata; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

5.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

6.  Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.

Authors:  Nicola Antonio Colabufo; Francesco Berardi; Marialessandra Contino; Mauro Niso; Carmen Abate; Roberto Perrone; Vincenzo Tortorella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-31       Impact factor: 3.000

7.  Sigma-2 ligands induce tumour cell death by multiple signalling pathways.

Authors:  C Zeng; J Rothfuss; J Zhang; W Chu; S Vangveravong; Z Tu; F Pan; K C Chang; R Hotchkiss; R H Mach
Journal:  Br J Cancer       Date:  2012-01-17       Impact factor: 7.640

8.  Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats.

Authors:  Anna A Rybczynska; Philip H Elsinga; Jurgen W Sijbesma; Kiichi Ishiwata; Johan R de Jong; Erik F de Vries; Rudi A Dierckx; Aren van Waarde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

9.  Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses.

Authors:  Kristoffer Sahlholm; Jurgen W A Sijbesma; Bram Maas; Chantal Kwizera; Daniel Marcellino; Nisha K Ramakrishnan; Rudi A J O Dierckx; Philip H Elsinga; Aren van Waarde
Journal:  Psychopharmacology (Berl)       Date:  2015-07-11       Impact factor: 4.530

10.  Sigma-1 Agonist Binding in the Aging Rat Brain: a MicroPET Study with [(11)C]SA4503.

Authors:  Nisha K Ramakrishnan; Anniek K D Visser; Anna A Rybczynska; Csaba J Nyakas; Paul G M Luiten; Chantal Kwizera; Jurgen W A Sijbesma; Philip H Elsinga; Kiichi Ishiwata; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2016-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.